chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Accidentally received 3rd dose; This spontaneous case was reported by a consumer and describes the occurrence of EXTRA DOSE ADMINISTERED (Accidentally received 3rd dose) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Bone disorder (NOS) and Migraine. Concomitant products included ALENDRONATE SODIUM (FOSAMAX) for Bone disorder (NOS), SUMATRIPTAN (IMITREX [SUMATRIPTAN]) for Migraine.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXTRA DOSE ADMINISTERED (Accidentally received 3rd dose). On 26-Aug-2021, EXTRA DOSE ADMINISTERED (Accidentally received 3rd dose) had resolved.            Patient received 3rd dose of Moderna vaccine accidentally instead of receiving shingles vaccine.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, SARS-CoV-1 test, Vaccination site pain
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (experiencing shortness of breath, somewhat manageable,shortness of breath got worse, it was really tough at work,feels like she has to take really deep breaths.) and VACCINATION SITE PAIN (pain in the arm where she received injection, but that pain has subsided) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053E21A) for COVID-19 vaccination.No Medical History information was reported. On 24-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Aug-2021, the patient experienced DYSPNOEA (experiencing shortness of breath, somewhat manageable,shortness of breath got worse, it was really tough at work,feels like she has to take really deep breaths.). On an unknown date, the patient experienced VACCINATION SITE PAIN (pain in the arm where she received injection, but that pain has subsided). At the time of the report, DYSPNOEA (experiencing shortness of breath, somewhat manageable,shortness of breath got worse, it was really tough at work,feels like she has to take really deep breaths.) had not resolved and VACCINATION SITE PAIN (pain in the arm where she received injection, but that pain has subsided) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available):On an unknown date, SARS-CoV-1 test: negative (Negative) Negative.The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concurrent and treatment medication was reported by patient.Patient reported that shortness of breath got worse on 26 Aug 2021. Patient also mentioned that her kids have asthma and she wants to go home and use their asthma nebulizer.
Sex: U
Vaccine: COVID19
Symptoms: Myalgia, Pyrexia
Clinical narrative: Im having fever; Im having  lot of body pain; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Im having fever) and MYALGIA (Im having  lot of body pain) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Im having fever) and MYALGIA (Im having  lot of body pain). At the time of the report, PYREXIA (Im having fever) and MYALGIA (Im having  lot of body pain) outcome was unknown.            Concomitant medication was not provided Treatment information was not reported
Sex: F
Vaccine: COVID19
Symptoms: Adverse drug reaction, Product dose omission issue
Clinical narrative: missed second dose; had bad reaction; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (missed second dose) and ADVERSE DRUG REACTION (had bad reaction) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed second dose) and ADVERSE DRUG REACTION (had bad reaction). At the time of the report, PRODUCT DOSE OMISSION ISSUE (missed second dose) and ADVERSE DRUG REACTION (had bad reaction) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing was delayed on an unknown date.       No concomitant product was provided by the reporter. No treatment medication was provided.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: delayed second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (delayed second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jul-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (delayed second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (delayed second dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient got monoclonal antibodies on 27JUL2021, wants to know if there is any interactions and do still need to wait the 90 days even though it is the second dose? No concomitant medications were provided by reporter. No treatment medications were provided by reporter.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes (Patient is on Diabetes medication).    On 20-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Feb-2021, the patient experienced PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 21-Feb-2021, PYREXIA (Fever) had resolved.            This case was linked to MOD-2021-297879, MOD-2021-297903 (Patient Link).
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Nausea, Pain in extremity
Clinical narrative: I have been so dizzy; Also have diarrhea; Arms are a little sore; Chills; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (I have been so dizzy), DIARRHOEA (Also have diarrhea), PAIN IN EXTREMITY (Arms are a little sore), CHILLS (Chills) and NAUSEA (Nauseous) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 059E214) for COVID-19 vaccination.     Concurrent medical conditions included Lung cancer stage III. Concomitant products included LOSARTAN, ASPIRIN [ACETYLSALICYLIC ACID] and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.    On 25-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Aug-2021, the patient experienced DIZZINESS (I have been so dizzy), DIARRHOEA (Also have diarrhea), PAIN IN EXTREMITY (Arms are a little sore), CHILLS (Chills) and NAUSEA (Nauseous). At the time of the report, DIZZINESS (I have been so dizzy), DIARRHOEA (Also have diarrhea), PAIN IN EXTREMITY (Arms are a little sore), CHILLS (Chills) and NAUSEA (Nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not reported by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 02-Sep-2021: Follow up contain no new information
Sex: M
Vaccine: COVID19
Symptoms: Adverse reaction, Arthralgia, Insomnia
Clinical narrative: first shot he had slight reactions; slept for a fewhours; his joints hurt a little bit; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (first shot he had slight reactions), INSOMNIA (slept for a fewhours) and ARTHRALGIA (his joints hurt a little bit) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Chronic lymphocytic leukemia.   On 19-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ADVERSE REACTION (first shot he had slight reactions), INSOMNIA (slept for a fewhours) and ARTHRALGIA (his joints hurt a little bit). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, ADVERSE REACTION (first shot he had slight reactions), INSOMNIA (slept for a fewhours) and ARTHRALGIA (his joints hurt a little bit) outcome was unknown.            No concomitant medications were provided.  He did not have reactions for the second dose.   Reporter did not allow further contact
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Feeling abnormal, Headache, Somnolence
Clinical narrative: Having trouble breathing/feel like my breathing is labored; feeling like I was in an Earthquake; I felt tired; Had a headache; Felt very sleepy; felt like I had a hangover and felt like I was in an earthquake; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Felt very sleepy), FEELING ABNORMAL (felt like I had a hangover and felt like I was in an earthquake), DYSPNOEA (Having trouble breathing/feel like my breathing is labored), TREMOR (feeling like I was in an Earthquake) and FATIGUE (I felt tired) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939676) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Aug-2021, the patient experienced SOMNOLENCE (Felt very sleepy), FATIGUE (I felt tired) and HEADACHE (Had a headache). 12-Aug-2021, the patient experienced FEELING ABNORMAL (felt like I had a hangover and felt like I was in an earthquake). On 25-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DYSPNOEA (Having trouble breathing/feel like my breathing is labored). 25-Aug-2021, the patient experienced TREMOR (feeling like I was in an Earthquake). On 14-Aug-2021, SOMNOLENCE (Felt very sleepy), FEELING ABNORMAL (felt like I had a hangover and felt like I was in an earthquake), FATIGUE (I felt tired) and HEADACHE (Had a headache) had resolved. At the time of the report, DYSPNOEA (Having trouble breathing/feel like my breathing is labored) and TREMOR (feeling like I was in an Earthquake) had not resolved.            Concomitant medications was not provided by the reporter. Treatment information was not provided.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-300209 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Having trouble breathing/feel like my breathing is labored; feeling like I was in an Earthquake; I felt tired; Had a headache; Felt very sleepy; felt like I had a hangover and felt like I was in an earthquake; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Felt very sleepy), FEELING ABNORMAL (felt like I had a hangover and felt like I was in an earthquake), DYSPNOEA (Having trouble breathing/feel like my breathing is labored), TREMOR (feeling like I was in an Earthquake) and FATIGUE (I felt tired) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 939676) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 11-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Aug-2021, the patient experienced SOMNOLENCE (Felt very sleepy), FATIGUE (I felt tired) and HEADACHE (Had a headache). 12-Aug-2021, the patient experienced FEELING ABNORMAL (felt like I had a hangover and felt like I was in an earthquake). On 25-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DYSPNOEA (Having trouble breathing/feel like my breathing is labored). 25-Aug-2021, the patient experienced TREMOR (feeling like I was in an Earthquake). On 14-Aug-2021, SOMNOLENCE (Felt very sleepy), FEELING ABNORMAL (felt like I had a hangover and felt like I was in an earthquake), FATIGUE (I felt tired) and HEADACHE (Had a headache) had resolved. At the time of the report, DYSPNOEA (Having trouble breathing/feel like my breathing is labored) and TREMOR (feeling like I was in an Earthquake) had not resolved.            Concomitant medications was not provided by the reporter. Treatment information was not provided.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-300209 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Injection site is a little feverish, warm; Injection site tight; Injection site itchy; Injection site is now red; Injection site raised; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Injection site is a little feverish, warm), VACCINATION SITE INDURATION (Injection site tight), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE ERYTHEMA (Injection site is now red) and VACCINATION SITE SWELLING (Injection site raised) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concurrent medical conditions included Ulcerative colitis.    On 19-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Aug-2021, the patient experienced VACCINATION SITE WARMTH (Injection site is a little feverish, warm), VACCINATION SITE INDURATION (Injection site tight), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE ERYTHEMA (Injection site is now red) and VACCINATION SITE SWELLING (Injection site raised). At the time of the report, VACCINATION SITE WARMTH (Injection site is a little feverish, warm), VACCINATION SITE INDURATION (Injection site tight), VACCINATION SITE PRURITUS (Injection site itchy), VACCINATION SITE ERYTHEMA (Injection site is now red) and VACCINATION SITE SWELLING (Injection site raised) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided.  No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Acute respiratory distress syndrome, Fatigue, Headache, Hypoxia, Inflammation
Clinical narrative: Pulmonary Distress Hypoxia; Viral pneumonia; Hypoxia; Inflammation; Fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ACUTE RESPIRATORY DISTRESS SYNDROME (Pulmonary Distress Hypoxia), PNEUMONIA VIRAL (Viral pneumonia) and HYPOXIA (Hypoxia) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Left anterior descending coronary artery stenosis.    On 01-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACUTE RESPIRATORY DISTRESS SYNDROME (Pulmonary Distress Hypoxia) (seriousness criteria hospitalization and medically significant), PNEUMONIA VIRAL (Viral pneumonia) (seriousness criteria hospitalization and medically significant), HYPOXIA (Hypoxia) (seriousness criteria hospitalization and medically significant), INFLAMMATION (Inflammation), FATIGUE (Fatigue) and HEADACHE (Headache). The patient was hospitalized on 02-Aug-2021 due to HYPOXIA and PNEUMONIA VIRAL. The patient was treated with REMDESIVIR for COVID-19, at an unspecified dose and frequency. At the time of the report, ACUTE RESPIRATORY DISTRESS SYNDROME (Pulmonary Distress Hypoxia), PNEUMONIA VIRAL (Viral pneumonia) and HYPOXIA (Hypoxia) had resolved and INFLAMMATION (Inflammation), FATIGUE (Fatigue) and HEADACHE (Headache) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Oxygen saturation: 80% (Low) 80%.         The concomitant medication were not provided.  The patient was in floor Isolation then ICU for heart and oxygen levels.On August second, the patient was the only Vaccinated patient to be Hospitalized for positive tested where the Delta was active.  Company Comment :This case concerns a patient with unknown age and gender with past medical history Diabetes Mellitus and Left anterior descending coronary artery stenosis, who had adverse events of Acute Respiratory Distress Syndrome, Pneumonia Viral, Hypoxia, Inflammation, Fatigue, Headache, and was subsequently hospitalized approximately after 4 months of receiving the 2nd dose of the vaccine. Very limited information regarding this events has been provided at this time. Further information has been requested.; Sender's Comments: This case concerns a patient with unknown age and gender with past medical history Diabetes Mellitus and Left anterior descending coronary artery stenosis, who had adverse events of Acute Respiratory Distress Syndrome, Pneumonia Viral, Hypoxia, Inflammation, Fatigue, Headache, and was subsequently hospitalized approximately after 4 months of receiving the 2nd dose of the vaccine. Very limited information regarding this events has been provided at this time. Further information has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Oxygen saturation, Pneumonia viral
Clinical narrative: Pulmonary Distress Hypoxia; Viral pneumonia; Hypoxia; Inflammation; Fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ACUTE RESPIRATORY DISTRESS SYNDROME (Pulmonary Distress Hypoxia), PNEUMONIA VIRAL (Viral pneumonia) and HYPOXIA (Hypoxia) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes and Left anterior descending coronary artery stenosis.    On 01-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACUTE RESPIRATORY DISTRESS SYNDROME (Pulmonary Distress Hypoxia) (seriousness criteria hospitalization and medically significant), PNEUMONIA VIRAL (Viral pneumonia) (seriousness criteria hospitalization and medically significant), HYPOXIA (Hypoxia) (seriousness criteria hospitalization and medically significant), INFLAMMATION (Inflammation), FATIGUE (Fatigue) and HEADACHE (Headache). The patient was hospitalized on 02-Aug-2021 due to HYPOXIA and PNEUMONIA VIRAL. The patient was treated with REMDESIVIR for COVID-19, at an unspecified dose and frequency. At the time of the report, ACUTE RESPIRATORY DISTRESS SYNDROME (Pulmonary Distress Hypoxia), PNEUMONIA VIRAL (Viral pneumonia) and HYPOXIA (Hypoxia) had resolved and INFLAMMATION (Inflammation), FATIGUE (Fatigue) and HEADACHE (Headache) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Oxygen saturation: 80% (Low) 80%.         The concomitant medication were not provided.  The patient was in floor Isolation then ICU for heart and oxygen levels.On August second, the patient was the only Vaccinated patient to be Hospitalized for positive tested where the Delta was active.  Company Comment :This case concerns a patient with unknown age and gender with past medical history Diabetes Mellitus and Left anterior descending coronary artery stenosis, who had adverse events of Acute Respiratory Distress Syndrome, Pneumonia Viral, Hypoxia, Inflammation, Fatigue, Headache, and was subsequently hospitalized approximately after 4 months of receiving the 2nd dose of the vaccine. Very limited information regarding this events has been provided at this time. Further information has been requested.; Sender's Comments: This case concerns a patient with unknown age and gender with past medical history Diabetes Mellitus and Left anterior descending coronary artery stenosis, who had adverse events of Acute Respiratory Distress Syndrome, Pneumonia Viral, Hypoxia, Inflammation, Fatigue, Headache, and was subsequently hospitalized approximately after 4 months of receiving the 2nd dose of the vaccine. Very limited information regarding this events has been provided at this time. Further information has been requested.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Muscle twitching, Myalgia, Nausea, Pain in extremity
Clinical narrative: Convulsing; Really sick; Twitching; Sore arm; Armpit swelling; Whole body hurt; 102.7°F fever; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of SEIZURE (Convulsing) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    In July 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, the patient experienced SEIZURE (Convulsing) (seriousness criterion medically significant), VACCINATION COMPLICATION (Really sick), MUSCLE TWITCHING (Twitching), PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Armpit swelling), MYALGIA (Whole body hurt), PYREXIA (102.7°F fever), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, SEIZURE (Convulsing), VACCINATION COMPLICATION (Really sick), MUSCLE TWITCHING (Twitching), PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Armpit swelling), MYALGIA (Whole body hurt), PYREXIA (102.7°F fever), CHILLS (Chills) and NAUSEA (Nausea) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       The  concomitant medications on use were not provided. No treatment information was provided.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-301455 (Patient Link).   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia, Seizure, Vaccination complication
Clinical narrative: Convulsing; Really sick; Twitching; Sore arm; Armpit swelling; Whole body hurt; 102.7°F fever; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of SEIZURE (Convulsing) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    In July 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, the patient experienced SEIZURE (Convulsing) (seriousness criterion medically significant), VACCINATION COMPLICATION (Really sick), MUSCLE TWITCHING (Twitching), PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Armpit swelling), MYALGIA (Whole body hurt), PYREXIA (102.7°F fever), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, SEIZURE (Convulsing), VACCINATION COMPLICATION (Really sick), MUSCLE TWITCHING (Twitching), PAIN IN EXTREMITY (Sore arm), PERIPHERAL SWELLING (Armpit swelling), MYALGIA (Whole body hurt), PYREXIA (102.7°F fever), CHILLS (Chills) and NAUSEA (Nausea) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       The  concomitant medications on use were not provided. No treatment information was provided.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-301455 (Patient Link).   Reporter did not allow further contact; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: Mother passed away; This spontaneous case was reported by a consumer and describes the occurrence of DEATH (Mother passed away) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Death occurred on an unknown date The cause of death was not reported. It is unknown if an autopsy was performed.            Concomitant product use was not provided by the reporter. Treatment information was not provided.   Reporter did not allow further contact; Sender's Comments: Very limited information regarding this event has been provided at this time. Further information has been requested to confirm if this is a valid case.; Reported Cause(s) of Death: Unknown cause of death
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Hypersomnia, Vomiting
Clinical narrative: Through up; Patient went to sleep on Friday night  and woke up on Sunday evening; Episodes of memory lost; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (Patient went to sleep on Friday night  and woke up on Sunday evening) and VOMITING (Through up) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 006M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder (Thyroid condition for about 40 years) and Addison's disease (Addison's disease for about 20 years). Concomitant products included PREDNISONE, FLUDROCORTISONE and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced HYPERSOMNIA (Patient went to sleep on Friday night  and woke up on Sunday evening) (seriousness criterion hospitalization). On 14-Mar-2021, the patient experienced VOMITING (Through up) (seriousness criterion hospitalization). On an unknown date, the patient experienced AMNESIA (Episodes of memory lost). The patient was hospitalized from 14-Mar-2021 to 15-Mar-2021 due to HYPERSOMNIA and VOMITING. On 14-Mar-2021, HYPERSOMNIA (Patient went to sleep on Friday night  and woke up on Sunday evening) had resolved. On 15-Mar-2021, VOMITING (Through up) had resolved. At the time of the report, AMNESIA (Episodes of memory lost) had not resolved.            Treatment information was not provided.  Additional information reported included that the patient was scared of taking third dose.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However current condition such thyroid problem and Addison disease could be a confounder for this events, particularly with the ongoing event memory loss because patient stated he withdraw current medication for Addison disease.   Further information has been requested   This case was linked to MOD-2021-301942 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However current condition such thyroid problem and Addison desease could be a confounder for this events, particularly with the ongoing event memory loss because patient stated he withdraw current medication for Addison disease.   Further information has been requested
Sex: U
Vaccine: COVID19
Symptoms: Pericarditis
Clinical narrative: Pericarditis; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PERICARDITIS (Pericarditis) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERICARDITIS (Pericarditis) (seriousness criterion medically significant). At the time of the report, PERICARDITIS (Pericarditis) outcome was unknown.            No concomitant medication details was provided. No treatment medication details was provided.  Company comment: Based on the current available information and temporal association between the use of the product, and the start date of the event, a causal relationship cannot be excluded.  Date of first dose was not provided, thus appropriateness of product administration schedule is not assessable. Further information has been requested.; Sender's Comments: Based on the current available information and temporal association between the use of the product, and the start date of the event, a causal relationship cannot be excluded.  Date of first dose was not provided, thus appropriateness of product administration schedule is not assessable. Further information has been requested.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Gait disturbance, Memory impairment, Myalgia, Nausea
Clinical narrative: restless legs; coughing; Nausea; I'm having arm soreness/muscle aches; I'm having trouble walking aching; I'm having memory issues; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (I'm having trouble walking aching), MEMORY IMPAIRMENT (I'm having memory issues), RESTLESS LEGS SYNDROME (restless legs), COUGH (coughing) and NAUSEA (Nausea) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004F21A, 011J20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis. Concomitant products included TERIFLUNOMIDE (AUBAGIO), ARMODAFINIL (NUVIGIL), PREDNISONE and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Aug-2021, the patient experienced GAIT DISTURBANCE (I'm having trouble walking aching), MEMORY IMPAIRMENT (I'm having memory issues) and MYALGIA (I'm having arm soreness/muscle aches). On an unknown date, the patient experienced RESTLESS LEGS SYNDROME (restless legs), COUGH (coughing) and NAUSEA (Nausea). At the time of the report, GAIT DISTURBANCE (I'm having trouble walking aching), MEMORY IMPAIRMENT (I'm having memory issues), RESTLESS LEGS SYNDROME (restless legs), COUGH (coughing), NAUSEA (Nausea) and MYALGIA (I'm having arm soreness/muscle aches) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications were not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 02-Sep-2021: Follow up received on 02-Sep-2021 and case seriousness was upgraded from non-serious to serious and Detail's about patient hospitalization was reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product, and the start date of the events, a causal relationship cannot be excluded.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Restless legs syndrome
Clinical narrative: restless legs; coughing; Nausea; I'm having arm soreness/muscle aches; I'm having trouble walking aching; I'm having memory issues; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (I'm having trouble walking aching), MEMORY IMPAIRMENT (I'm having memory issues), RESTLESS LEGS SYNDROME (restless legs), COUGH (coughing) and NAUSEA (Nausea) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004F21A, 011J20A and 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Multiple sclerosis. Concomitant products included TERIFLUNOMIDE (AUBAGIO), ARMODAFINIL (NUVIGIL), PREDNISONE and COLECALCIFEROL (VITAMIN D [COLECALCIFEROL]) for an unknown indication.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Aug-2021, the patient experienced GAIT DISTURBANCE (I'm having trouble walking aching), MEMORY IMPAIRMENT (I'm having memory issues) and MYALGIA (I'm having arm soreness/muscle aches). On an unknown date, the patient experienced RESTLESS LEGS SYNDROME (restless legs), COUGH (coughing) and NAUSEA (Nausea). At the time of the report, GAIT DISTURBANCE (I'm having trouble walking aching), MEMORY IMPAIRMENT (I'm having memory issues), RESTLESS LEGS SYNDROME (restless legs), COUGH (coughing), NAUSEA (Nausea) and MYALGIA (I'm having arm soreness/muscle aches) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medications were not provided by reporter.   Most recent FOLLOW-UP information incorporated above includes: On 02-Sep-2021: Follow up received on 02-Sep-2021 and case seriousness was upgraded from non-serious to serious and Detail's about patient hospitalization was reported.; Sender's Comments: Based on the current available information and temporal association between the use of the product, and the start date of the events, a causal relationship cannot be excluded.
Sex: U
Vaccine: COVID19
Symptoms: Thrombosis
Clinical narrative: Seen a rise in blood clots in younger individuals; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of THROMBOSIS (Seen a rise in blood clots in younger individuals) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (Seen a rise in blood clots in younger individuals) (seriousness criterion medically significant). At the time of the report, THROMBOSIS (Seen a rise in blood clots in younger individuals) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.   This case was linked to MOD-2021-003812 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Very itchy rash all over entire abdomen lasting about two weeks and slowly fading away
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Thrombosis
Clinical narrative: Blood Clot in left lowere leg, shin
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acute psychosis, Blood test, Computerised tomogram head, Electroencephalogram, Fatigue
Clinical narrative: Second dose of vaccine was given on 5/6/21, fatigue and fever present on 5/7/2021, acute psychosis began on 5/8/21 with suicidal ideation and hospitalized on 5/13/21 for 7 days and then transferred to psychiatric ward for 4 days. No prior mental health history and no family mental health history.
Age: 26.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Lumbar puncture, Magnetic resonance imaging head, Pyrexia, Suicidal ideation
Clinical narrative: Second dose of vaccine was given on 5/6/21, fatigue and fever present on 5/7/2021, acute psychosis began on 5/8/21 with suicidal ideation and hospitalized on 5/13/21 for 7 days and then transferred to psychiatric ward for 4 days. No prior mental health history and no family mental health history.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Lethargy, Nausea, Pain, Pyrexia
Clinical narrative: Systemic: Body Aches Generalized-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Fever-Medium, Systemic: Nausea-Medium, Additional Details: patient's temp is elevated at 102 degrees and feels lethargic. advised to call PCP
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Limb injury, Paraesthesia
Clinical narrative: Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Illness, Injection site swelling, Pyrexia, Rash
Clinical narrative: Rash all over arm, hand, and neck only on the side of the shot. Swelling around injection sight. Fever and sick day after shot.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Error: Wrong Dose of Vaccine - Too Low-
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Burning sensation
Clinical narrative: Painful joints bilateral hands first three fingers. Bilateral wrists painful joints. Burning fire pain problems with bending fingers.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Error: Patient Too Young for Vaccine Administered-
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation  (ex. different manufacture. initial and booster)-
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered
Clinical narrative: Error: Wrong Vaccine Formulation  (ex. different manufacture. initial and booster)-
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Injection site erythema, Injection site pain, Injection site swelling, Mouth swelling
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face, Swollen tongue
Clinical narrative: Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Medium, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: patient passed out in chair-Severe
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Diarrhoea, Nausea
Clinical narrative: Stomach cramps,  nausea, diarrhea every day, off and on since shot.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site erythema, Injection site pain, Injection site swelling, Pyrexia
Clinical narrative: Site: Pain at Injection Site-Medium, Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Severe, Systemic: Fever-Mild, Systemic: Headache-Mild
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema
Clinical narrative: Site: Redness at Injection Site-Medium
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Site: Pain at Injection Site-Severe
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chest X-ray, Computerised tomogram thorax, Immediate post-injection reaction, Laboratory test
Clinical narrative: PATIENT DEVELOPED COVID-19 IMMEDIATELY AFTER RECEIVING THE J&J VACCINE, HE THEN DEVELOPED HYPOXIC RESPIRATORY FAILURE DUE TO COVID AND THEN 2.5 WEEKS LATER HAS DEVELOPED SEVERE HYPOXIC RESPIRATORY FAILURE DUE TO EXTENSIVE BILATERAL BACTERIAL PNEUMONIA WITH SEPSIS.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pneumonia bacterial, Respiratory failure, Sepsis
Clinical narrative: PATIENT DEVELOPED COVID-19 IMMEDIATELY AFTER RECEIVING THE J&J VACCINE, HE THEN DEVELOPED HYPOXIC RESPIRATORY FAILURE DUE TO COVID AND THEN 2.5 WEEKS LATER HAS DEVELOPED SEVERE HYPOXIC RESPIRATORY FAILURE DUE TO EXTENSIVE BILATERAL BACTERIAL PNEUMONIA WITH SEPSIS.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Injection site pruritus, Injection site swelling, Urticaria
Clinical narrative: Site: Itching at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Additional Details: pt seems to be fine overall . will use some benadryl to alleviate itching sensations.  will instruct pt to get shot on oppostive arm on follow up appointment. classified pt as non severe allergic reaction because pt got hives within 4 hours of getting pfizer shot so cdc recommends to not get a second shot.  this is clearly stated to pt. and pt understands this that this is her only shot.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Computerised tomogram thorax, Echocardiogram normal, Myocarditis, Pyrexia
Clinical narrative: Patient developed fever, chest pain w/i 2 days of vaccine.   He was admitted on 9/5/2021 to   and diagnosed with myocarditis.
Age: 17.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin increased
Clinical narrative: Patient developed fever, chest pain w/i 2 days of vaccine.   He was admitted on 9/5/2021 to   and diagnosed with myocarditis.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: RN had diffuse urticarial rash that appeared 9 hours after receiving Moderna vaccine (1st dose) today.  No wheezing, difficulty breathing or throat discomfort reported.  Lungs were clear. Throat exam was normal.  Code blue was activated. Vitals signs were normal. She was given Benadryl 50 mg PO x 1 & transferred.
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19
Clinical narrative: Patient developed COVID-19
Age: 74.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Patient developed COVID-19
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Headache, Injected limb mobility decreased, Injection site pain, Pruritus
Clinical narrative: 08/29/21 Pain site of injection could not lift arm above shoulder 2 days 09/01/21 Rash on neck and chest Applied cortizone creme subsized itchiness 09/03/21 Severe headache lasted 2 days  Took advil did not help, next day took BC powder helped for few hours but came back 09/05/21 2 bruises ( dime size) back of arm Notice distance vision  blurry while driving 09/06/21 2 bruises on front of arm Bruises on back of arm disappeared
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vision blurred
Clinical narrative: 08/29/21 Pain site of injection could not lift arm above shoulder 2 days 09/01/21 Rash on neck and chest Applied cortizone creme subsized itchiness 09/03/21 Severe headache lasted 2 days  Took advil did not help, next day took BC powder helped for few hours but came back 09/05/21 2 bruises ( dime size) back of arm Notice distance vision  blurry while driving 09/06/21 2 bruises on front of arm Bruises on back of arm disappeared
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Induration, Pain in extremity, Thrombosis, Ultrasound scan
Clinical narrative: Pain, bruising and hardness to an area on my medial lower thigh.  It was a blood clot in my leg. I never had a blood clot. I saw a vascular surgeon and started wearing compression socks. The bruising is still there but the pain and hardness went away.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus, Skin warm
Clinical narrative: "Red swollen arm. The size of an medium apple. Warm to the touch. Very itch." Symptoms still remain 5 days after vaccination. Patient instructed to take Benadryl, and acetaminophen at the 5 day mark after vaccination.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Vaginal haemorrhage
Clinical narrative: Unexpected vaginal bleeding, severe lower back pain.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Limb discomfort, Pruritus
Clinical narrative: Injection site was painful and "heavy" in the first 1-3 days similar to other immunizations. On Sept 6, day 4 after the shot my left arm felt very itchy.  The site became swollen and red over the next several hours and up to the time of this report.  The swollen site is about 2.5 inches in diameter from the shot site.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Condition aggravated, Death
Clinical narrative: Death due to COVID-19